Retatrutide / GLP3 (30mg)
$145.00
Quantity
Summary: Triple receptor agonist (GLP-1/GIP/GCG) for obesity & metabolic research.
Chemical Data:
Formula: C73H111N17O18
MW: 1490.8 g/mol
Purity: >99% (HPLC/MS)
CAS: 2226512-80-2
Key Studies:
NEJM (2023): 24.2% weight loss over 48 weeks (PubMed)
Cell Metabolism (2022): Synergy of GLP-1/GIP/GCG pathways for glycemic control (PubMed)
Mechanism: Activates GLP-1 (satiety), GIP (insulin sensitivity), glucagon (energy expenditure).
Research Focus: Obesity, Type 2 Diabetes, Cardiometabolic Health.